- Home
- DSP vs AQST Comparison
DSP vs AQST Comparison
Compare DSP & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSP
- AQST
- Stock Information
- Founded
- DSP 1999
- AQST 2004
- Country
- DSP United States
- AQST United States
- Employees
- DSP N/A
- AQST N/A
- Industry
- DSP EDP Services
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- DSP Technology
- AQST Health Care
- Exchange
- DSP Nasdaq
- AQST Nasdaq
- Market Cap
- DSP 220.3M
- AQST 272.9M
- IPO Year
- DSP 2021
- AQST 2018
- Fundamental
- Price
- DSP $13.78
- AQST $3.72
- Analyst Decision
- DSP Strong Buy
- AQST Strong Buy
- Analyst Count
- DSP 8
- AQST 6
- Target Price
- DSP $21.75
- AQST $10.67
- AVG Volume (30 Days)
- DSP 238.8K
- AQST 1.5M
- Earning Date
- DSP 08-11-2025
- AQST 08-05-2025
- Dividend Yield
- DSP N/A
- AQST N/A
- EPS Growth
- DSP N/A
- AQST N/A
- EPS
- DSP 0.13
- AQST N/A
- Revenue
- DSP $306,484,000.00
- AQST $54,228,000.00
- Revenue This Year
- DSP $18.36
- AQST N/A
- Revenue Next Year
- DSP $15.95
- AQST $45.71
- P/E Ratio
- DSP $106.28
- AQST N/A
- Revenue Growth
- DSP 30.64
- AQST 5.29
- 52 Week Low
- DSP $8.70
- AQST $2.12
- 52 Week High
- DSP $26.33
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- DSP 48.96
- AQST 68.53
- Support Level
- DSP $12.79
- AQST $3.13
- Resistance Level
- DSP $13.58
- AQST $3.33
- Average True Range (ATR)
- DSP 0.57
- AQST 0.22
- MACD
- DSP 0.06
- AQST 0.01
- Stochastic Oscillator
- DSP 76.06
- AQST 94.17
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.